Estrella Immunopharma Inc — Cash Flow (NASDAQ:ESLA) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities -316.16 K-1.04 M-16.07 M -3.83 M Cash from investing activities -45.19 M36.17 M4.96 M — Cash from financing activities 45.98 M-35.56 M12.79 M 2.17 M Free cash flow -316.16 K-1.04 M-16.07 M -3.83 M

Haberler

Estrella riporta tasso di risposta completa del 100% in trial sul linfoma

Estrella reports 100% complete response rate in lymphoma trial

Estrella presenterà i dati della fase 1 sulla terapia cellulare mirata a CD19

Estrella to present phase 1 data on CD19-targeted cell therapy

Estrella Immunopharma riceve avviso dal Nasdaq per ritardo nell’assemblea annuale

Estrella Immunopharma receives Nasdaq notice for delayed annual meeting

Estrella Immunopharma chiude un’offerta diretta registrata di 8 milioni di dollari

Estrella Immunopharma closes $8 million registered direct offering

Il titolo di Estrella Immunopharma crolla dopo l’annuncio di un’offerta di 8 milioni

Estrella Immunopharma stock falls after announcing $8 million offering

Estrella Immunopharma raccoglie 8 milioni di dollari tramite offerta registrata

Estrella Immunopharma raises $8 million through registered offering